Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official. Federal government websites often end in . gov or . mil. Before sharing sensitive information, make sure you’re on a federal government site VSports app下载. .

Https

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. V体育官网.

Review
. 2016 Aug 22:7:264.
doi: 10.3389/fphar.2016.00264. eCollection 2016.

CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation

Juan Zhou  1 , Ian Burkovskiy  2 , Hyewon Yang  1 , Joel Sardinha  3 , Christian Lehmann  4
Affiliations
Review

CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation

Juan Zhou et al. Front Pharmacol. .

Abstract

The endocannabinoid system (ECS) is involved in many physiological processes and has been suggested to play a critical role in the immune response and the central nervous system (CNS). Therefore, ECS modulation has potential therapeutic effects on immune dysfunctional disorders, such as sepsis and CNS injury-induced immunodeficiency syndrome (CIDS). In sepsis, excessive release of pro- and anti-inflammatory mediators results in multi-organ dysfunction, failure, and death. In CIDS, an acute CNS injury dysregulates a normally well-balanced interplay between CNS and the immune system, leading to increased patients' susceptibility to infections. In this review, we will discuss potential therapeutic modulation of the immune response in sepsis and CNS injury by manipulation of the ECS representing a novel target for immunotherapy VSports手机版. .

Keywords: CNS injury-induced immunodeficiency syndrome; GPR55; central nervous system injury; endocannabinoid system; immune dysfunction; immunosuppression; sepsis. V体育安卓版.

PubMed Disclaimer

References

    1. Adhikary S., Li H., Heller J., Skarica M., Zhang M., Ganea D., et al. (2011). Modulation of inflammatory responses by a cannabinoid-2-selective agonist after spinal cord injury. J. Neurotrauma 28 2417–2427. 10.1089/neu.2011.1853 - DOI - PMC - PubMed
    1. Al-Banna N. A., Toguri J. T., Kelly M. E., Lehmann C. H. (2013). Leukocyte endothelial interactions within the ocular microcirculation in inflammation and infection. Clin. Hemorheol. Microcirc. 55 423–443. 10.3233/CH-131780 - DOI (VSports注册入口) - PubMed
    1. Alvarez F. J., Lafuente H., Rey-Santano M. C., Mielgo V. E., Gastiasoro E., Rueda M., et al. (2008). Neuroprotective effects of the nonpsychoactive cannabinoid cannabidiol in hypoxic-ischemic newborn piglets. Pediatr. Res. 64 653–658. 10.1203/PDR.0b013e318186e5dd - DOI - PubMed
    1. Baker D., Pryce G., Davies W. L., Hiley C. R. (2006). In silico patent searching reveals a new cannabinoid receptor. Trends Pharmacol. Sci. 27 1–4. 10.1016/j.tips.2005.11.003 - DOI - PubMed
    1. Balenga N. A., Aflaki E., Kargl J., Platzer W., Schröder R., Blättermann S., et al. (2011). GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils. Cell Res. 21 1452–1469. 10.1038/cr.2011.60 - DOI - PMC - PubMed

Publication types